Skip to main content

Zanubrutinib

(ZAN-yoo-BROO-tih-nib)

This page contains brief information about zanubrutinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Brukinsa
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Zanubrutinib is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that zanubrutinib provides a clinical benefit in these patients.

Zanubrutinib is also being studied in the treatment of other types of cancer.

More About Zanubrutinib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Zanubrutinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: